| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.03B | +11.3% |
| Cost of Revenue | $1.59B | +19.6% |
| Gross Profit | $2.44B | +6.5% |
| R&D Expense | $552.4M | +9.2% |
| SG&A Expense | $1.29B | +8.5% |
| Operating Income | $600.0M | +0.4% |
| Interest Expense | $14.9M | -26.6% |
| Pre-tax Income | $709.0M | -0.2% |
| Income Tax | $132.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $606.1M | +7.0% |
| Accounts Receivable | $1.01B | +3.3% |
| Inventory | $542.6M | -3.0% |
| Current Assets | $4.30B | -2.8% |
| Total Assets | $6.48B | +3.5% |
| Current Liabilities | $2.93B | +88.4% |
| Total Liabilities | $4.38B | +4.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $989.5M | +32.2% |
| Capital Expenditures | $358.8M | +51.6% |
| Investing Cash Flow | -$207.5M | +59.1% |
| Financing Cash Flow | -$734.8M | -130.6% |
| Free Cash Flow | $630.7M | +23.2% |
| -21.4% |
| Net Income | $576.2M | +6.4% |
| EPS (Basic) | $1.46 | +4.3% |
| EPS (Diluted) | $1.42 | +9.2% |
| Stockholders' Equity |
| $2.10B |
| +1.6% |